N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Expanding Medication-Assisted Therapies in Central Asia

Sponsor: Yale University • ClinicalTrials.gov ID: NCT05579470

Registry updated: 2026-10-14
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy to scale-up OAT in three diverse Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan) and guided by the Exploration-Planning-Implementation-Sustainment (EPIS) framework. Understanding the trajectories of implementation and scale-up in this context may emerge through creating communities of practice, especially when cohesion and competence evolves, and may guide other healthcare delivery challenges in the region (e.g., HIV, TB); as well as build important regional expertise and understanding implementation trajectories should help support OAT program sustainability.

Interventions

  • NIATx (Behavioral)
    For each country, the learning collaborative will be comprised of a Chief Narcologist from each region where the investigators will initially train them and the coaches using all the tools from the NIATx Academy (2-3-day training). The national coach for each country will receive ongoing and in-depth coaching from a US-based super coach. A nationwide Nominal Group Technique (NGT) will be conducted to assess barriers and potential targets to guide decision-making about changes. At the end of the initial meeting, each Chief Narcologist (CN) will be able to identify a change target for Plan, Do, Study, Act (PDSA) (entry, retention) and create a Change Project Form to state what will be done (e.g. flowcharting), who is involved (team), what are the measures and timeframe (\<4 weeks).

Eligibility criteria

Inclusion Criteria: i. Aim 1: The inclusion criteria for Aim 1 Consists of: 1. Quantitative surveys for PWID 1. 18 years or older 2. Meeting DSM-V criteria for opioid dependence 3. Be either treatment naïve and seeking OAT or be on OAT for \< 90 days 2. Organizational Assessments for OAT Delivery Staff 1. 18 years or older 2. Currently working as an OAT delivery professional at an OAT delivery site 3. Focus Groups (PWID on OAT) 1. 18 years or older 2. Meeting DSM-V criteria for opioid dependence 3. Be either treatment naïve and seeking OAT or be on OAT for \< 90 days 4. Focus Groups (PWID not on OAT) 1. 18 years or older 2. Meeting Diagnostic and Statistical Manual of Mental Disorders(DSM)-V criteria for opioid dependence 3. Be OAT naïve (defined as never having been on OAT or having not received treatment for \> 1 year) 5. Focus Groups (OAT delivery staff) 1. 18 years or older 2. Currently working as an OAT delivery professional at an OAT delivery site ii. Aim 2: The inclusion criteria for Aim 2 consists of: 1. 18 years or older 2. Currently assigned as a Chief Narcologist for an Oblast iii. Aim 3: The inclusion criteria for Aim 3 consists of: 1. 18 years or older 2. Authorized as a professional to work at an OAT delivery site Exclusion Criteria: * Not willing to provide consent

Conditions

Opioid Use Disorder

Locations

  • Yale University — New Haven, Connecticut, United States
  • Columbia University Global Health Research Center of Central Asia — Almaty, Kazakhstan
  • Den Sooluk Nuru — Bishkek, Kyrgyzstan
  • Institute for International Health and Education — Dushanbe, Tajikistan
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record